Skip to main content
Smart Investors Daily
AC

NASDAQ · ACB

Aurora Cannabis Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$4.16

Down-$0.10 (-2.35%)

Updated Nov 21, 2026, 8:51 PM

SID Score

5.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
217.76M
P/E ratio
7.31
Dividend yield
0.00%
52-week range
$2.56 – $6.36
Volume
900.39K
Avg. volume
1.65M

Price performance · ACB

ACB price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 20, 2026

ACB closed at $4.16 after 21 trading sessions, up 7.22% for the selected period.

Last close
$4.16
Period change
+7.22%
Period low
$3.88
Period high
$5.24
Daily close
View OHLC price history
ACB OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 20, 2026$4.23$4.35$4.145$4.16900.39K
Nov 19, 2026$4.40$4.43$4.255$4.26913.52K
Nov 18, 2026$4.52$4.58$4.38$4.40934.12K
Nov 17, 2026$4.59$4.615$4.49$4.52830.49K
Nov 16, 2026$4.88$4.91$4.4747$4.612.81M
Nov 13, 2026$4.98$5.03$4.865$4.941.44M
Nov 12, 2026$5.00$5.10$4.98$4.992M
Nov 11, 2026$5.10$5.10$5.05$5.05699.16K
Nov 10, 2026$5.14$5.29$5.0902$5.111.43M
Nov 9, 2026$5.25$5.30$5.15$5.161.91M
Nov 6, 2026$5.10$5.24$5.08$5.242.09M
Nov 5, 2026$5.20$5.30$5.055$5.195.13M
Nov 4, 2026$5.16$5.26$5.10$5.243.18M
Nov 3, 2026$4.71$5.20$4.71$5.169.01M
Nov 2, 2026$4.16$4.34$4.09$4.222.04M
Oct 30, 2026$4.03$4.09$3.98$4.06807.14K
Oct 29, 2026$4.05$4.14$4.04$4.08509.99K
Oct 28, 2026$4.09$4.10$3.985$4.08555.46K
Oct 27, 2026$3.90$4.155$3.90$4.15579.16K
Oct 26, 2026$3.85$3.95$3.84$3.90494.67K
Oct 23, 2026$3.96$3.96$3.87$3.88602.88K

Latest ACB news

The latest Smart Investors Daily articles mentioning ACB.

ACB research

Overview

Company profile and research snapshot.

Company profile

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$5.92
Implied upside
—
Analysts
9
ACB recent ratings
DateFirmRatingTarget
Aug 19, 2026ATB CAPITAL MARKETSOutperform—
Aug 18, 2026TD COWENBuy—
Aug 5, 2026CANACCORD GENUITYBuy—
Aug 5, 2026ROTH CAPITAL PARTNERSNeutral—
Aug 5, 2026ZUANIC & ASSOCIATESNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 14, 2026

3 Canadian Healthcare Stocks With Up To 30% Revenue Growth

Wholesale inflation in the United States is running at a 6.5% annual rate, according to the latest producer price data, and central bankers keep saying policy will follow inflation. That kind of backdrop often pushes investors toward essential services. Healthcare in Canada fits that description. This article walks through three high quality Canadian healthcare stocks from our curated list to help you assess potential opportunities. The three Canadian healthcare stocks covered next are just a...

Yahoo · Nov 11, 2026

Curaleaf Holdings (TSX:CURA) Clears Key Hurdle As Its Cannabis Deal Nears Closing

Curaleaf Holdings (TSX:CURA) reported that it has received all required competition law approvals for its proposed Aurora Cannabis acquisition. Regulators in Germany and Canada cleared the transaction, addressing key antitrust questions in two core cannabis markets. The latest approvals mean Curaleaf and Aurora Cannabis can move closer to closing a deal that could reshape their market positions. The competition law clearance for the Aurora Cannabis acquisition is a key development to weigh...

Yahoo · Nov 10, 2026

Curaleaf Receives All Required Competition Law Clearances for Proposed Acquisition of Aurora Cannabis

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (the "Company"), a leading international provider of consumer and medical cannabis products, today announced that it has received competition law clearances in Germany and Canada for its proposed acquisition of Aurora Cannabis Inc. ("Aurora"). Germany and Canada are the only jurisdictions in which competition law clearance was required for Curaleaf's proposed acquisition.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.